Abstract
Background
Inflammation is one of major contributors of diabetic osteoporosis. Here, we combined adipose tissues derived mesenchymal stem cells (AD-MSCs)-derived exosomes and microRNA-146a (miR-146a) to develop more effective anti-inflammation strategy in osteoclasts.
Methods
miR-146a was overexpressed in AD-MSCs and miR-146a exosomes (miR-146a-Exo) were isolated and characterized. Cellular and animal diabetic osteoporosis models were created to evaluate the anti-inflammation effect of miR-146a-Exo by using ELISA, qRT-PCR, MTT, bone resorption assay, Western blot, and bone mineral content and density analysis in vitro and in vivo.
Results
miR-146a-Exo administration presented the most potent effect on inhibition of pro-inflammatory cytokines production in high glucose-treated osteoclasts, restraint bone resorption, and restoration of the bone loss in streptozotocin-induced diabetic osteoporosis rats. Mechanistically, miR-146a-Exo suppressed the expression of TNF-α, IL-18, and IL-1β, induced the inactivation of inflammasome, and finally reduced bone resorption and recovered bone loss.
Conclusion
Combination of AD-MSCs-Exo and miR-146a more effectively exert the anti-inflammation effect in osteoclasts, providing a potential drug for the treatment of diabetic osteoporosis.
Similar content being viewed by others
References
Hamann, C., S. Kirschner, K. P. Gunther, and L. C. Hofbauer. Bone, sweet bone–osteoporotic fractures in diabetes mellitus. Nat. Rev. Endocrinol. 8(5):297–305, 2012.
Saito, M., and K. Marumo. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 21(2):195–214, 2010.
Cheloni, R., S. A. Gandolfi, C. Signorelli, and A. Odone. Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis. BMJ Open. 9(3):e022188, 2019.
Reilly, J. J., A. El-Hamdouchi, A. Diouf, A. Monyeki, and S. A. Somda. Determining the worldwide prevalence of obesity. Lancet. 391(10132):1773–1774, 2018.
Harding, J. L., M. E. Pavkov, D. J. Magliano, J. E. Shaw, and E. W. Gregg. Global trends in diabetes complications: a review of current evidence. Diabetologia. 62(1):3–16, 2019.
Vlassara, H., and J. Uribarri. Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr. Diabetes Rep. 14(1):453, 2014.
Asadipooya, K., and E. M. Uy. Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature. J. Endocr. Soc. 3(10):1799–1818, 2019.
Agidigbi, T. S., and C. Kim. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int. J. Mol. Sci. 20(14):3576, 2019.
Domazetovic, V., G. Marcucci, T. Iantomasi, M. L. Brandi, and M. T. Vincenzini. Oxidative stress in bone remodeling: role of antioxidants. Clin. Cases Miner. Bone Metab. 14(2):209–216, 2017.
Kanazawa, I. Interaction between bone and glucose metabolism [Review]. Endocr. J. 64(11):1043–1053, 2017.
De Martinis, M., M. M. Sirufo, C. Nocelli, L. Fontanella, and L. Ginaldi. Hyperhomocysteinemia is associated with inflammation, bone resorption, Vitamin B12 and folate deficiency and MTHFR C677T polymorphism in postmenopausal women with decreased bone mineral density. Int. J. Environ. Res. Public Health. 17(12):4260, 2020.
Rao, S. S., Y. Hu, P. L. Xie, J. Cao, Z. X. Wang, J. H. Liu, H. Yin, J. Huang, Y. J. Tan, J. Luo, M. J. Luo, S. Y. Tang, T. H. Chen, L. Q. Yuan, E. Y. Liao, R. Xu, Z. Z. Liu, C. Y. Chen, and H. Xie. Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines. Bone Res. 6:9, 2018.
Tofino-Vian, M., M. I. Guillen, M. D. Perez Del Caz, A. Silvestre, and M. J. Alcaraz. Microvesicles from human adipose tissue-derived mesenchymal stem cells as a new protective strategy in osteoarthritic chondrocytes. Cell Physiol. Biochem. 47(1):11–25, 2018.
Yun, B., B. E. Maburutse, M. Kang, M. R. Park, D. J. Park, Y. Kim, and S. Oh. Short communication: dietary bovine milk-derived exosomes improve bone health in an osteoporosis-induced mouse model. J. Dairy Sci. 103(9):7752–7760, 2020.
Yang, C., W. Lim, J. Park, S. Park, S. You, and G. Song. Anti-inflammatory effects of mesenchymal stem cell-derived exosomal microRNA-146a-5p and microRNA-548e-5p on human trophoblast cells. Mol. Hum. Reprod. 25(11):755–771, 2019.
Lo, W. Y., C. T. Peng, and H. J. Wang. MicroRNA-146a-5p mediates high glucose-induced endothelial inflammation via targeting interleukin-1 receptor-associated kinase 1 expression. Front. Physiol. 8:551, 2017.
Boldin, M. P., K. D. Taganov, D. S. Rao, L. Yang, J. L. Zhao, M. Kalwani, Y. Garcia-Flores, M. Luong, A. Devrekanli, J. Xu, G. Sun, J. Tay, P. S. Linsley, and D. Baltimore. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208(6):1189–1201, 2011.
Chang, C. L., P. H. Sung, K. H. Chen, P. L. Shao, C. C. Yang, B. C. Cheng, K. C. Lin, C. H. Chen, H. T. Chai, H. W. Chang, H. K. Yip, and H. H. Chen. Adipose-derived mesenchymal stem cell-derived exosomes alleviate overwhelming systemic inflammatory reaction and organ damage and improve outcome in rat sepsis syndrome. Am. J. Transl. Res. 10(4):1053–1070, 2018.
Vestergaard, P. Bone metabolism in type 2 diabetes and role of thiazolidinediones. Curr. Opin. Endocrinol. Diabetes Obes. 16(2):125–131, 2009.
Li, B., A. Hock, R. Y. Wu, A. Minich, S. R. Botts, C. Lee, L. Antounians, H. Miyake, Y. Koike, Y. Chen, A. Zani, P. M. Sherman, and A. Pierro. Bovine milk-derived exosomes enhance goblet cell activity and prevent the development of experimental necrotizing enterocolitis. PLoS ONE. 14(1):e0211431, 2019.
Georgess, D., M. Mazzorana, J. Terrado, C. Delprat, C. Chamot, R. M. Guasch, I. Perez-Roger, P. Jurdic, and I. Machuca-Gayet. Comparative transcriptomics reveals RhoE as a novel regulator of actin dynamics in bone-resorbing osteoclasts. Mol. Biol. Cell. 25(3):380–396, 2014.
Ren, Z. Y., I. Machuca-Gayet, C. Domenget, R. Buchet, Y. Wu, P. Jurdic, and S. Mebarek. Azanitrile cathepsin K inhibitors: effects on cell toxicity, osteoblast-induced mineralization and osteoclast-mediated bone resorption. PLoS ONE. 10(7):e0132513, 2015.
Wei, M., L. Ong, M. T. Smith, F. B. Ross, K. Schmid, A. J. Hoey, D. Burstow, and L. Brown. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ. 12(1):44–50, 2003.
An, Y., H. Zhang, C. Wang, F. Jiao, H. Xu, X. Wang, W. Luan, F. Ma, L. Ni, X. Tang, M. Liu, W. Guo, and L. Yu. Activation of ROS/MAPKs/NF-kappaB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB J. 33(11):12515–12527, 2019.
Baek, D., J. Villen, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel. The impact of microRNAs on protein output. Nature. 455(7209):64–71, 2008.
Baltimore, D., M. P. Boldin, R. M. O’Connell, D. S. Rao, and K. D. Taganov. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9(8):839–845, 2008.
Sheedy, F. J., E. Palsson-McDermott, E. J. Hennessy, C. Martin, J. J. O’Leary, Q. Ruan, D. S. Johnson, Y. Chen, and L. A. O’Neill. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11(2):141–147, 2010.
Tokuhiro, S., R. Yamada, X. Chang, A. Suzuki, Y. Kochi, T. Sawada, M. Suzuki, M. Nagasaki, M. Ohtsuki, M. Ono, H. Furukawa, M. Nagashima, S. Yoshino, A. Mabuchi, A. Sekine, S. Saito, A. Takahashi, T. Tsunoda, Y. Nakamura, and K. Yamamoto. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35(4):341–348, 2003.
Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103(33):12481–12486, 2006.
Baraban, J. M., A. Shah, and X. Fu. Multiple pathways mediate microRNA degradation: focus on the translin/Trax RNase complex. Adv. Pharmacol. 82:1–20, 2018.
Zhang, Z., Y. W. Qin, G. Brewer, and Q. Jing. MicroRNA degradation and turnover: regulating the regulators. Wiley Interdiscip. Rev. RNA. 3(4):593–600, 2012.
Pers, Y. M., M. Ruiz, D. Noel, and C. Jorgensen. Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthritis Cartilage. 23(11):2027–2035, 2015.
Singer, N. G., and A. I. Caplan. Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. 6:457–478, 2011.
Bouffi, C., C. Bony, C. Jorgensen, and D. Noel. Skin fibroblasts are potent suppressors of inflammation in experimental arthritis. Ann. Rheum. Dis. 70(9):1671–1676, 2011.
Luz-Crawford, P., D. Noel, X. Fernandez, M. Khoury, F. Figueroa, F. Carrion, C. Jorgensen, and F. Djouad. Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway. PLoS ONE. 7(9):e45272, 2012.
Picke, A. K., G. Campbell, N. Napoli, L. C. Hofbauer, and M. Rauner. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties. Endocr. Connect. 8(3):R55–R70, 2019.
Wu, H., H. Fan, Z. Shou, M. Xu, Q. Chen, C. Ai, Y. Dong, Y. Liu, Z. Nan, Y. Wang, T. Yu, and X. Liu. Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1. Int. Immunopharmacol. 68:204–212, 2019.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Lei Zhang, Qinghai Wang, Hang Su, and Jiaxiang Cheng declare that they have no conflict of interest.
Ethical Approval
No human studies were carried out by the authors for this article. All animal studies were carried out in accordance with the Guide for the Care and Use of Laboratory Animals (8th edition, NIH), and were approved by the ethical committee of Cangzhou Central Hospital.
Additional information
Associate Editor Michael R. King oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, L., Wang, Q., Su, H. et al. Exosomes from Adipose Tissues Derived Mesenchymal Stem Cells Overexpressing MicroRNA-146a Alleviate Diabetic Osteoporosis in Rats. Cel. Mol. Bioeng. 15, 87–97 (2022). https://doi.org/10.1007/s12195-021-00699-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12195-021-00699-4